๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
277 KB
Volume
22
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

โœฆ Synopsis


Amyotrophic lateral sclerosis (ALS) and its variants are feared progressive neurological diseases of which the etiology and pathogenesis are unknown and for which therapy is unavailable. In 1983, Engel and associates 1 11 reported that infusion of thyrotropin-releasing hormone (TRH) improved strength and lessened spasticity in patients with ALS. Their report generated hope that, at long last, an effective treatment may exist. In this report we assess the current status of the evidence for using TRH in the management of patients with ALS.


๐Ÿ“œ SIMILAR VOLUMES


Light therapy and supplementary riboflav
โœ Helina Moges; Olavo M. Vasconcelos; William W. Campbell; Rosemary C. Borke; Jenn ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 231 KB

## Abstract ## Background and Objective Familial amyotrophic lateral sclerosis (FALS) is a neurodegenerative disease characterized by progressive loss of motor neurons and death. Mitochondrial dysfunction and oxidative stress play an important role in motor neuron loss in ALS. Light therapy (LT) h

Gene therapy flexes muscle : A European
โœ Thierry VandenDriessche ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 45 KB

## Abstract This commentary highlights the promising results of recent studies in animal models of Duchenne muscular dystrophy and amyotrophic lateral sclerosis that have clearly demonstrated the potential of gene therapy for tackling these diseases. In the absence of effective drugs or other treat